Antibiotics and the Nervous System—Which Face of Antibiotic Therapy Is Real, Dr. Jekyll (Neurotoxicity) or Mr. Hyde (Neuroprotection)?
Open accessThe DOI matches its Crossref record; 134 of the 135 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Antibiotics as antibacterial drugs have saved many lives, but have also become a victim of their own success. Their widespread abuse reduces their anti-infective effectiveness and causes the development of bacterial resistance. Moreover, irrational antibiotic therapy contributes to gastrointestinal dysbiosis, that increases the risk of the development of many diseases, including neurological and psychiatric. One of the potential options for restoring homeostasis is the use of oral antibiotics that are poorly absorbed from the gastrointestinal tract (e.g., rifaximin alfa). Thus, antibiotic therapy may exert neurological or psychiatric adverse drug reactions which are often considered to be overlooked and undervalued issues. Drug-induced neurotoxicity is mostly observed after beta-lactams and quinolones. Penicillin may produce a wide range of neurological dysfunctions, including encephalopathy, behavioral changes, myoclonus or seizures. Their pathomechanism results from the disturbances of gamma-aminobutyric acid-GABA transmission (due to the molecular similarities between the structure of the β-lactam ring and GABA molecule) and impairment of the functioning of benzodiazepine receptors (BZD). However, on the other hand, antibiotics have also been studied for their neuroprotective properties in the treatment of neurodegenerative and neuroinflammatory processes (e.g., Alzheimer’s or Parkinson’s diseases). Antibiotics may, therefore, become promising elements of multi-targeted therapy for these entities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Generally, although promising, two main concerns remain about the use of antibiotics in PD treatment: (i) antibiotics can kill some specific microbial populations leading to intestinal dysbiosis and neurological dysfunction and (ii) their prolonged and widespread intake would favor antibiotic resistance [213,300,301].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [213]
The cited source says what the claim attributes to it.
In the citing paper
“Generally, although promising, two main concerns remain about the use of antibiotics in PD treatment: (i) antibiotics can kill some specific microbial populations leading to intestinal dysbiosis and neurological dysfunction and (ii) their prolonged and widespread intake would favor antibiotic resistance [213,300,301].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [213]
In the citing paper
“certain antibiotics can inhibit the activity of matrix metalloproteinases and prevent mitochondria dysfunction, microglia activation, protein misfolding and α-synuclein aggregation [211,212,213,214,215]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [213]
In the citing paper
“Moreover, quinolones and β-lactams are known to trigger neurotoxicity through their interference with gamma-aminobutyric acid and benzodiazepine receptors signaling [213].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [213]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The antibiotic resistance crisis: part 1: causes and threats.
Ventola, C. L. (2015) · PubMed Central · Cited by 8,022
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Gut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052 · cited 1×
“Spontaneous mutations are also an important cause, allowing the acquisition of bacterial resistance to antibiotics without the exchange of genetic material between various strains [5].”
BackgroundAdverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
(2015) · PubMed Central · Cited by 2,540
Antibiotics: past, present and future
Hutchings, M. I., Truman, A. W., & Wilkinson, B. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.10.008 · Cited by 2,370 · cited 1×
“The discovery of antibiotic agents and their introduction into clinical practice is considered to be one of the greatest medical breakthrough of the 20th century [1].”
BackgroundGut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · cited 1×
“It was also found that higher concentrations of Enterobacteriaceae were directly proportional to gait and postural instability [34,43].”
BackgroundA brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628 · cited 3×
“in Medicine or Physiology in 1945 for the discovery of penicillin and its curative effect in various infectious diseases) [2,3].”
BackgroundHuman gut microbiome: Hopes, threats and promises
Cani, P. D. (2018) · Gut · doi:10.1136/gutjnl-2018-316723 · Cited by 1,386
Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U. P., Paghera, B., Muscio, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.019 · Cited by 1,382 · cited 1×
“Abnormal gut microbiota may produce a large number of amyloids and other toxins and act as a source of systemic inflammation, thus contributing to increased risk of Alzheimer’s disease development [34,41].”
BackgroundMartin, C. R., Osadchiy, V., Kalani, A., & Mayer, E. A. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.04.003 · Cited by 1,284 · cited 10×
“The intestinal dysbiosis also predisposes to Parkinson’s disease development due to the fact that gut inflammatory pathomechanisms play a significant role in alpha-synuclein misfolding [34,42].”
BackgroundResultInfluentialAntimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Abdul-Aziz, M. H., Alffenaar, J.-W. C., Bassetti, M., Bracht, H., Dimopoulos, G., Marriott, D., Neely, M. N., Paiva, J.-A., Pea, F., Sjovall, F., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06050-1 · Cited by 1,081
Fogel, D. B. (2018) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2018.08.001 · Cited by 1,035
The Human Microbiota in Health and Disease
Wang, B., Yao, M., Lv, L., Ling, Z., & Li, L. (2017) · Engineering · doi:10.1016/j.eng.2017.01.008 · Cited by 850
The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology
Rutsch, A., Kantsjö, J. B., & Ronchi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604179 · Cited by 821
Pham, T. D. M., Ziora, Z. M., & Blaskovich, M. A. T. (2019) · MedChemComm · doi:10.1039/c9md00120d · Cited by 785
`Ome Sweet `Omics--A Genealogical Treasury of Words
Lederberg, J., & McCray, A. T. (2001) · The Scientist (Philadelphia, Pa. Online)/The Scientist · Cited by 736
Comparative Review of the Carbapenems
Zhanel, G. G., Wiebe, R., Dilay, L., Thomson, K., Rubinstein, E., Hoban, D. J., Noreddin, A. M., & Karlowsky, J. A. (2007) · Drugs · doi:10.2165/00003495-200767070-00006 · Cited by 652
Colonic inflammation in Parkinson's disease
Devos, D., Lebouvier, T., Lardeux, B., Biraud, M., Rouaud, T., Pouclet, H., Coron, E., Bruley des Varannes, S., Naveilhan, P., Nguyen, J.-M., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.09.007 · Cited by 627 · cited 1×
“The intestinal dysbiosis also predisposes to Parkinson’s disease development due to the fact that gut inflammatory pathomechanisms play a significant role in alpha-synuclein misfolding [34,42].”
BackgroundAminoglycoside-Induced Ototoxicity
Selimoglu, E. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207779313731 · Cited by 446
Neurotoxic effects associated with antibiotic use: management considerations
Grill, M. F., & Maganti, R. K. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03991.x · Cited by 410 · cited 18×
“There are two barriers to GBA signaling: the intestinal barrier and the blood–brain barrier (BBB).”
BackgroundInfluentialColeman, J. J., & Pontefract, S. K. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-5-481 · Cited by 399
Follesa, P., Biggio, F., Gorini, G., Caria, S., Talani, G., Dazzi, L., Puligheddu, M., Marrosu, F., & Biggio, G. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.045 · Cited by 352 · cited 1×
“There is also evidence that the dysbiosis-induced stimulation of the vagal nerve, that conveys information between the gut and the central nervous system, intensifies the expression of neurotrophic elements determining the development of new neurons and synaptic connections, which has been shown to be associated with…”
BackgroundGABA ‐producing Bifidobacterium dentium modulates visceral sensitivity in the intestine
Pokusaeva, K., Johnson, C., Luk, B., Uribe, G., Fu, Y., Oezguen, N., Matsunami, R. K., Lugo, M., Major, A., Mori‐Akiyama, Y., et al. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.12904 · Cited by 337 · cited 1×
“impacting the production or response to neurotransmitters (GABA, serotonin) [34,39,40].”
BackgroundSekhar, R. V., Patel, S. G., Guthikonda, A. P., Reid, M., Balasubramanyam, A., Taffet, G. E., & Jahoor, F. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.003483 · Cited by 336 · cited 1×
“This hypothesis would be in line with the observations that sulfonamide neurological ADRs are often noticed in HIV-infected or geriatric patients with depleted endogenous reserves of glutathione [67,68].”
ResultToo much of a good thing: a retrospective study of β-lactam concentration–toxicity relationships
Imani, S., Buscher, H., Marriott, D., Gentili, S., & Sandaradura, I. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx209 · Cited by 320
Renal and neurological side effects of colistin in critically ill patients
Spapen, H., Jacobs, R., Van Gorp, V., Troubleyn, J., & Honoré, P. M. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-14 · Cited by 281
The use of vancomycin with its therapeutic and adverse effects: a review.
Bruniera, F. R., Ferreira, F. M., Saviolli, L. R. M., Bacci, M. R., Feder, D., Pedreira, M. D. L. G., Peterlini, M. A. S., Azzalis, L. A., Junqueira, V. B. C., & Fonseca, F. L. A. (2015) · PubMed · Cited by 275
Antibiotics: from prehistory to the present day
Gould, K. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv484 · Cited by 268 · cited 2×
“in Medicine or Physiology in 1945 for the discovery of penicillin and its curative effect in various infectious diseases) [2,3].”
BackgroundOn-Site Therapeutic Drug Monitoring
Ates, H. C., Roberts, J. A., Lipman, J., Cass, A. E. G., Urban, G. A., & Dincer, C. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2020.03.001 · Cited by 268
Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model
Wu, S., Yi, J., Zhang, Y.-G., Zhou, J., & Sun, J. (2015) · Physiological Reports · doi:10.14814/phy2.12356 · Cited by 267 · cited 3×
“In an experimental ALS mouse model, a tight junction structure, greater intestinal permeability, and an abnormal microbiota profile with lower butyrate-producing bacteria were observed compared to controls.”
BackgroundBorgo, F., Riva, A., Benetti, A., Casiraghi, M. C., Bertelli, S., Garbossa, S., Anselmetti, S., Scarone, S., Pontiroli, A. E., Morace, G., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179739 · Cited by 267
The Neurotoxicity of Antibacterial Agents
SNAVELY, S. R., & HODGES, G. R. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-92 · Cited by 249
Risk Factors for the Development of Auditory Toxicity in Patients Receiving Aminoglycosides
Moore, R. D., Smith, C. R., & Lietman, P. S. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/149.1.23 · Cited by 238
Chastre, J., Wunderink, R., Prokocimer, P., Lee, M., Kaniga, K., & Friedland, I. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181691b99 · Cited by 237
Update on the adverse effects of antimicrobial therapies in community practice.
Mohsen, S. T., Dickinson, J. A., & Somayaji, R. (2020) · PubMed Central · Cited by 217
Clinical Pharmacology of Antibiotics
Eyler, R. F., & Shvets, K. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08140718 · Cited by 212
Grill, M. F., & Maganti, R. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l307 · Cited by 201 · cited 1×
“The variety of clinical presentation, ranging from simple EEG abnormalities to mental status changes, myoclonus, seizures or even coma have been reported within all four generations of cephalosporins, with the most frequent findings related to cefepime, cefoperazone, ceftazidine, cefuroxime and cefazolin [60,80].”
BackgroundNeurotoxicity induced by beta-lactam antibiotics: from bench to bedside
Chow, K. M., Hui, A. C., & Szeto, C. C. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0021-y · Cited by 183 · cited 2×
“Thus, GABA complex receptor inhibition via competitive (for cephalosporins) or non-competitive affecting of the GABAA subunits is the basic hypothesis for beta lactam neurotoxicity [26,84,85].”
BackgroundAntibiotic Adverse Reactions and Drug Interactions
Granowitz, E. V., & Brown, R. B. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2007.12.011 · Cited by 177 · cited 2×
“Post-antibiotic neurological disorders are manifested by hearing loss or labyrinthine dysfunction (characteristic for erythromycin and azithromycin), and by ototoxicity and vestibular dysfunction (pathognomonic for aminoglycosides) or by other forms of neurotoxicity, affecting either peripheral or the central nervous…”
BackgroundNeurotoxicity of β-lactam antibiotics: predisposing factors and pathogenesis
Schliamser, S. E., Cars, O., & Norrby, S. R. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.4.405 · Cited by 158
Optimizing antimicrobial use: challenges, advances and opportunities
Rawson, T. M., Wilson, R. C., O’Hare, D., Herrero, P., Kambugu, A., Lamorde, M., Ellington, M. J., Georgiou, P., Cass, A. E. G., Hope, W. W., et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00578-9 · Cited by 157
de Velde, F., Mouton, J. W., de Winter, B. C. M., van Gelder, T., & Koch, B. C. P. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.005 · Cited by 156
Neurotoxicity with Antimicrobials in the Elderly: A Review
Mattappallil, A., & Mergenhagen, K. A. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.09.020 · Cited by 143 · cited 18×
“There are two barriers to GBA signaling: the intestinal barrier and the blood–brain barrier (BBB).”
BackgroundInfluentialClinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature
Goolsby, T. A., Jakeman, B., & Gaynes, R. P. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.08.033 · Cited by 123 · cited 1×
“However, the symptoms are observed to resolve after the discontinuation of the therapy in most patients [53].”
BackgroundANTIBIOTIC-INDUCED CONVULSIONS
Wallace, K. L. (1997) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70367-5 · Cited by 119
ADVERSE REACTIONS OF NITROFURANTOIN, TRIMETHOPRIM AND SULFAMETHOXAZOLE IN CHILDREN
KARPMAN, E., & KURZROCK, E. A. (2004) · Journal of Urology · doi:10.1097/01.ju.0000130653.74548.d6 · Cited by 118 · cited 1×
“Of note, the SMX/TMP neurotoxicity is less commonly reported in children, probably due to the lower doses used in the therapy, the lack of significant concurrent diseases and drug interactions resulting from polypharmacotherapy [69].”
BackgroundThe Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib
Buclin, T., Thoma, Y., Widmer, N., André, P., Guidi, M., Csajka, C., & Decosterd, L. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00177 · Cited by 118
Antibiotic-induced epileptic seizures: mechanisms of action and clinical considerations
Wanleenuwat, P., Suntharampillai, N., & Iwanowski, P. S. (2020) · Seizure · doi:10.1016/j.seizure.2020.08.012 · Cited by 117 · cited 2×
“Colistin neurotoxicity primarily involving paresthesias, and in only sporadic cases apnea, especially in patients with intramuscular administration of the drug, with acute or chronic renal failure and receiving medications, induces respiratory muscle weakness [99,105].”
BackgroundMiller, A. D., Ball, A. M., Bookstaver, P. B., Dornblaser, E. K., & Bennett, C. L. (2011) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.31.4.408 · Cited by 109
Neurotoxic Concentration of Piperacillin during Continuous Infusion in Critically Ill Patients
Quinton, M.-C., Bodeau, S., Kontar, L., Zerbib, Y., Maizel, J., Slama, M., Masmoudi, K., Lemaire‐Hurtel, A., & Bennis, Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00654-17 · Cited by 104
Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review
Deshayes, S., Coquerel, A., & Verdon, R. (2017) · Drug Safety · doi:10.1007/s40264-017-0578-2 · Cited by 104 · cited 3×
“The leaflet dedicated to these preparations mentions the possibility of seizures, confusion, dizziness, vertigo, paresthesia or insomnia, but they are reported very rarely [70,71].”
BackgroundThe ability of biogenic amines and ammonia production by single bacterial cultures
Özoğul, F., & Özoğul, Y. (2006) · European Food Research and Technology · doi:10.1007/s00217-006-0429-3 · Cited by 101 · cited 1×
“impacting the production or response to neurotransmitters (GABA, serotonin) [34,39,40].”
BackgroundGatell, J. M., Ferran, F., Araujo, V., Bonet, M., Soriano, E., Traserra, J., & SanMiguel, J. G. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.9.1383 · Cited by 101
Diazepam as a Treatment for Metronidazole Toxicosis in Dogs: A Retrospective Study of 21 Cases
Evans, J., Levesque, D. C., Knowles, K., Longshore, R., & Plummer, S. B. (2003) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2003.tb02452.x · Cited by 96 · cited 1×
“The hypothesis is in line with the experimental observations that central metronidazole-associated neurotoxicity is ameliorated by diazepam [59].”
ResultThe Therapeutic Role of Minocycline in Parkinson’s Disease
Cankaya, S., Cankaya, B., Kilic, U., Kilic, E., & Yulug, B. (2019) · Drugs in Context · doi:10.7573/dic.212553 · Cited by 93
Safety and efficacy of glycopeptide antibiotics
Finch, R. G., & Eliopoulos, G. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki004 · Cited by 91 · cited 2×
“Ototoxicity with teicoplanin has been observed, but it does not occur often [92].”
BackgroundBarreto, E. F., Webb, A. J., Pais, G. M., Rule, A. D., Jannetto, P. J., & Scheetz, M. H. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000446 · Cited by 88
Therapeutic drug monitoring of amikacin in septic patients
Duszyńska, W., Taccone, F. S., Hurkacz, M., Kowalska−Krochmal, B., Wiela−Hojeńska, A., & Kübler, A. (2013) · Critical Care · doi:10.1186/cc12844 · Cited by 86
Self-citationMechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity
Steyger, P. S. (2021) · American Journal of Audiology · doi:10.1044/2021_aja-21-00006 · Cited by 86
Jaspard, M., Butel, N., Helali, N. E., Marigot-Outtandy, D., Guillot, H., Peytavin, G., Véziris, N., Bodaghi, B., Flandre, P., Petitjean, G., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2608.191499 · Cited by 82
Wallace, M., Miller, L. K., Nguyen, M.-T., & Shields, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91030-8 · Cited by 81
Therapeutic role of rifampicin in Alzheimer's disease
Yulug, B., Hanoglu, L., Ozansoy, M., Isık, D., Kilic, U., Kilic, E., & Schabitz, W. R. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12637 · Cited by 81
Neuropsychiatric Effects of Antimicrobial Agents
Zareifopoulos, N., & Panayiotakopoulos, G. D. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0498-z · Cited by 79 · cited 3×
“Metronidazole use is associated with the risk of both central and peripheral neurotoxicity [48,50,55].”
BackgroundRoy, U. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/19032.8054 · Cited by 77
Doxycycline for Alzheimer’s Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
Balducci, C., & Forloni, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00738 · Cited by 76
Novelli, A., & Rosi, E. (2017) · Journal of Chemotherapy · doi:10.1080/1120009x.2017.1380357 · Cited by 74
Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review
Yimer, E. M., Hishe, H. Z., & Tuem, K. B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00236 · Cited by 72
Swanson, D. J., Sung, R. J., Fine, M. J., Orloff, J. J., Chu, S.-Y., & Yu, V. L. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90016-5 · Cited by 70
Mechanisms of antibiotic neurotoxicity in renal failure
Chow, K. M., Szeto, C., Hui, A. C.-F., & Li, P. K. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.11.004 · Cited by 67 · cited 1×
“Acute ototoxicity is related to ion channel blockade and calcium antagonism and chronic ototoxicity is based on drug access to perilymph and endolymph, and penetration of the hair cells [101].”
BackgroundDrug-induced neurotoxicity in addiction medicine
Ahmadi‐Soleimani, S. M., Ekhtiari, H., & Cadet, J. L. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.004 · Cited by 65 · cited 1×
“, polydrug abuse, formation of neurotoxic metabolites during endogenous drug metabolism) and individual related factors (age, gender, gestational drug exposure, antioxidant status, diet) or influence of environmental conditions (chronic stress, temperature, exposure to environmental toxins and pollutions) [14,15].”
BackgroundHaruki, H., Hovius, R., Pedersen, M. G., & Johnsson, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.c115.680488 · Cited by 64 · cited 1×
“, serotonin or dopamine, thus the resulting disturbances in central neurotransmission may be coresponsible for the generation of symptoms of transient psychosis [66].”
BackgroundSeizures in the Critically Ill: The Role of Imipenem
Koppel, B. S., Hauser, W. A., Politis, C., van Duin, D., & Daras, M. D. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.34701.x · Cited by 62
The Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases
Obrenovich, M., Jaworski, H., Tadimalla, T., Mistry, A., Sykes, L., Perry, G., & Bonomo, R. (2020) · Microorganisms · doi:10.3390/microorganisms8050784 · Cited by 62 · cited 1×
“On the other hand, if properly applied, by eliminating pathogenic bacterial strains, antibiotics can significantly reduce the risk of neurological disorders resulting from GBA abnormalities [47].”
BackgroundIrreversible Sensorineural Hearing Loss as a Result of Azithromycin Ototoxicity: A Case Report
Ress, B. D., & Gross, E. M. (2000) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348940010900416 · Cited by 58
Antibiotic dose optimization in critically ill patients
Cotta, M. O., Roberts, J. A., & Lipman, J. (2015) · Medicina Intensiva · doi:10.1016/j.medin.2015.07.009 · Cited by 55
The expanding role of the antibiotic pharmacist
Weller, T. M. A., & Jamieson, C. E. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh327 · Cited by 54
Metronidazole-Induced Encephalopathy: Not Always a Reversible Situation
Hobbs, K. S., Stern-Nezer, S. J., Buckwalter, M. S., Fischbein, N. J., & Caulfield, A. F. (2015) · Neurocritical Care · doi:10.1007/s12028-014-0102-9 · Cited by 53
Scavone, C., Mascolo, A., Ruggiero, R., Sportiello, L., Rafaniello, C., Berrino, L., & Capuano, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00428 · Cited by 52
Psychosis as an adverse effect of antibiotics
Essali, N., & Miller, B. J. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100148 · Cited by 51
Erythromycin Ototoxicity and Acute Psychotic Reaction in Cancer Patients With Hepatic Dysfunction
Umstead, G. S., & Neumann, K. H. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360170099016 · Cited by 49
Neurotoxicity of the antibiotics: A comprehensive study
Alavi, S. A. N., Rezaei, N. J., & Bazzazi, A. (2018) · Neurology India · doi:10.4103/0028-3886.246258 · Cited by 49 · cited 18×
“There are two barriers to GBA signaling: the intestinal barrier and the blood–brain barrier (BBB).”
BackgroundResultInfluentialDrugs inducing hearing loss, tinnitus, dizziness and vertigo: an updated guide.
ALTISSIMI, G., Colizza, A., Cianfrone, G., VINCENTIIS, M. D., Greco, A., Taurone, S., Musacchio, A., Ciofalo, A., Turchetta, R., Angeletti, D., et al. (2020) · PubMed · doi:10.26355/eurrev_202008_22477 · Cited by 49
Psychiatric side effects of medications prescribed in internal medicine
Tango, R. C. (2003) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2003.5.2/rcasagrandetango · Cited by 46 · cited 1×
“Therefore, it is recommended to reduce rationally both the duration of treatment and adopted doses while maintaining its effectiveness [50,51].”
BackgroundAntibiotic-Induced Neurotoxicity
Bhattacharyya, S., Darby, R., & Berkowitz, A. L. (2014) · Current Infectious Disease Reports · doi:10.1007/s11908-014-0448-3 · Cited by 45
Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization
Simonetti, O., Rizzetto, G., Molinelli, E., Cirioni, O., & Offidani, A. (2021) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s271445 · Cited by 44 · cited 1×
“Currently available data suggests that the second generation lipoglycopeptides, dalbavancin and oritavancin, have no effect on hearing loss or dysfunction [95,96].”
BackgroundSmith, N. L., Freebairn, R. C., Park, M. A. J., Wallis, S. C., Roberts, J. A., & Lipman, J. (2012) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01773-8 · Cited by 41
Feasibility of a Short-Arm Centrifuge for Mouse Hypergravity Experiments
Morita, H., Obata, K., Abe, C., Shiba, D., Shirakawa, M., Kudo, T., & Takahashi, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133981 · Cited by 41 · cited 1×
“The results of some studies demonstrated that persistent, low-grade inflammation as a result of a “leaky gut” predisposes the host to the development of anorexia nervosa, depression and anxiety conditions [34,45,46].”
ResultMetronidazole-Induced Encephalopathy in a Patient with End-Stage Liver Disease
Knorr, J. P., Javed, I., Sahni, N., Cankurtaran, C. Z., & Ortiz, J. (2012) · Case Reports in Hepatology · doi:10.1155/2012/209258 · Cited by 41
Lin, C., Cheng, C., Lin, S., & Chou, C.-H. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31803195e7 · Cited by 39 · cited 1×
“Among the penicillin agents, piperacillin and tazobactam appear to be most potent to produce neurotoxicity symptoms [60,76,77], although ampicillin or benzylpenicillin-induced epileptogenic potential has also been reported in the literature [78,79].”
BackgroundAmpicillin-Induced Neurotoxicity in Very-Low-Birth-Weight Neonates
Shaffer, C. L., Davey, A. M., Ransom, J. L., Brown, Y. L., & Gal, P. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17228 · Cited by 38 · cited 1×
“Among the penicillin agents, piperacillin and tazobactam appear to be most potent to produce neurotoxicity symptoms [60,76,77], although ampicillin or benzylpenicillin-induced epileptogenic potential has also been reported in the literature [78,79].”
BackgroundDuszyńska, W., Taccone, F. S., Świtała, M., Hurkacz, M., Kowalska−Krochmal, B., & Kübler, A. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.10.011 · Cited by 36
Self-citationLee, K.-Y., Huang, C., Tang, H.-J., Yang, C., Ko, W., Chen, Y., Lee, Y., & Hung, C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks283 · Cited by 34 · cited 1×
“[63] demonstrated that almost 12% of HIV-infected patients with P.”
BackgroundAntimicrobial-induced cognitive side effects
Warstler, A., & Bean, J. (2016) · Mental Health Clinician · doi:10.9740/mhc.2016.07.207 · Cited by 34 · cited 4×
“Analogous to penicillin, they may mediate DIAM through specific drug-IgG binding in cerebrospinal fluid [49].”
BackgroundInfluentialSerious Neurological Adverse Events of Ceftriaxone
Lacroix, C., Jonville‐Béra, A. ‐., Montastruc, F., Velly, L. J., Micallef, J., & Guilhaumou, R. (2021) · Antibiotics · doi:10.3390/antibiotics10050540 · Cited by 34 · cited 1×
“Reported CNS ADRs between 1995 and 2017 identified ceftriaxone as both the leading cause of hospitalization and life-threatening situations, or even death [81].”
BackgroundEffect of Ceftazidime on Systemic Cytokine Concentrations in Rats
Alkharfy, K. M., Kellum, J. A., Frye, R. F., & Matzke, G. R. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3217-3219.2000 · Cited by 33
Trimethoprim‐Sulfamethoxazole‐Induced Tremor in an Immunocompetent Patient
Patterson, R. G., & Couchenour, R. L. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.18.1456.30903 · Cited by 32 · cited 1×
“Moreover, SMX/TMP administration was also reported to be, rarely, associated with the aseptic meningitis development or transient-occurring tremor in immunocompromised patients [64,65].”
BackgroundClinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients
K.‐W., T., Chow, K.-M., Choy, A. S. M., Kwan, B. C., Szeto, C., & Li, P. K.-T. (2014) · Clinical Kidney Journal · doi:10.1093/ckj/sfu098 · Cited by 32 · cited 1×
“The 56-year-old patient described them as “constantly evolving landscape of sharks, priests, red lines and other technicolor” [97].”
BackgroundGlycopeptide Hypersensitivity and Adverse Reactions
Huang, V., Clayton, N. A., & Welker, K. (2020) · Pharmacy · doi:10.3390/pharmacy8020070 · Cited by 32
Heffernan, A. J., Sime, F. B., Taccone, F. S., & Roberts, J. A. (2018) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000494 · Cited by 30
Metronidazole neurotoxicity: Sequential neuroaxis involvement
Park, K., Chung, J.-M., & Kim, J. (2011) · Neurology India · doi:10.4103/0028-3886.76882 · Cited by 27 · cited 2×
“Metronidazole use is associated with the risk of both central and peripheral neurotoxicity [48,50,55].”
BackgroundNERVOUS AND MENTAL EFFECTS OF THE SULFONAMIDES
LITTLE, S. C. (1942) · JAMA · doi:10.1001/jama.1942.02830230001001 · Cited by 27 · cited 1×
“The first reports of psychiatric disorders related to the use of sulfa drugs appeared as early as 1942 [61].”
BackgroundMetronidazole-Induced Neurotoxicity Developed in Liver Cirrhosis
Yamamoto, Y. (2012) · Journal of Clinical Medicine Research · doi:10.4021/jocmr893w · Cited by 27 · cited 1×
“Usually, the metronidazole-induced neurotoxicity is characterized by a gradual onset and mostly affects patients with concomitant renal and/or liver dysfunctions [56,57].”
BackgroundVanoverschelde, A., Oosterloo, B. C., Ly, N. F., Ikram, M. A., Goedegebure, A., Stricker, B. H. C., & Lahousse, L. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab232 · Cited by 27 · cited 1×
“It has been suggested that patients may recover from transient hearing loss associated with macrolide therapy, but develop tinnitus, which may be generated in the auditory centers of the brain by deviant neuronal activity caused by macrolide use [100].”
BackgroundTrimethoprim-sulfamethoxazole-related hallucinations
Štuhec, M. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.10.016 · Cited by 26
Huang, W.-S., Hsu, Y.-J., Chu, P., & Lin, S. (2009) · Infection · doi:10.1007/s15010-009-8373-3 · Cited by 25
Vancomycin-induced ototoxicity in very-low-birthweight infants
Marißen, J., Fortmann, M. I., Humberg, A., Rausch, T. K., Simon, A., Stein, A., Schaible, T., Eichhorn, J., Wintgens, J., Roll, C., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa156 · Cited by 25 · cited 1×
“Moreover, an explanation for this toxicity may be oxidative stress, which leads to loss of sensory cochlear cells [94].”
BackgroundGut-Brain Axis and its Neuro-Psychiatric Effects: A Narrative Review
Shaik, L., Kashyap, R., Thotamgari, S. R., Singh, R., & Khanna, S. (2020) · Cureus · doi:10.7759/cureus.11131 · Cited by 25 · cited 8×
“There are two barriers to GBA signaling: the intestinal barrier and the blood–brain barrier (BBB).”
BackgroundInfluentialA Rare Case of Cotrimoxazole-induced Eosinophilic Aseptic Meningitis in an HIV-infected Patient
Patey, O. (1998) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365549850161610 · Cited by 24
Impact of clinical pharmacist intervention on antimicrobial use in a small 164-bed hospital
Mas-Morey, P., Ballesteros-Fernández, A., Sanmartin-Mestre, E., & Valle, M. (2017) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2017-001307 · Cited by 24
Delusions Induced by Procaine Penicillin: Case Report and Review of the Syndrome
Cummings, J. L., Barritt, C. F., & Horan, M. (1987) · The International Journal of Psychiatry in Medicine · doi:10.2190/knqt-ueu4-gaq2-57l6 · Cited by 23 · cited 1×
“The attack usually lasts a few minutes and is preceded by residual asthenia and anxiety [73,74].”
BackgroundSalman, B. M., Al‐Hashar, A., Al-Khirbash, A., & Al-Zakwani, I. S. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.07.002 · Cited by 23
Zhang, J., Li, X., He, R., Zheng, W., Kwong, J. S.-W., Lu, L., Lv, T., Huang, R., He, M. T., Li, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.575022 · Cited by 22
Ilechukwu, S. T. C. (1990) · The British Journal of Psychiatry · doi:10.1192/bjp.156.4.554 · Cited by 20 · cited 1×
“The attack usually lasts a few minutes and is preceded by residual asthenia and anxiety [73,74].”
BackgroundNishikubo, M., Kanamori, M., & Nishioka, H. (2019) · Antibiotics · doi:10.3390/antibiotics8020078 · Cited by 16
Hoigné's syndrome: A procaine-induced limbic kindling
Araskiewicz, A., & RYBAKOWSKI, J. K. (1994) · Medical Hypotheses · doi:10.1016/0306-9877(94)90128-7 · Cited by 15 · cited 1×
“The potential underlying mechanism of the phenomena is that of embolic events in brain vessels, secondary to accidental penetration of procaine penicillin in the vascular system during injection or the direct toxic effect exerted by procaine with presumed limbic excitation [75].”
Background'Septrin psychosis' among renal transplant patients with Pneumocystis jirovecii pneumonia
Walker, L. E., Thomas, S., McBride, C., Howse, M., Turtle, L. C. W., Vivancos, R., Beeching, N. J., & Beadsworth, M. B. J. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr050 · Cited by 14 · cited 1×
“[62] confirmed the development of temporary psychosis in 20% of immunosuppressed HIV-negative, renal transplantation patients, with Pneumocystis jirovecii infection, treated with SMX/TMP.”
BackgroundUnmasking antibiotic-associated neurological disorders: The underminer in Intensive Care Unit
Xiao, M., & Huang, X. L. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.06.040 · Cited by 14 · cited 15×
“Analogous to penicillin, they may mediate DIAM through specific drug-IgG binding in cerebrospinal fluid [49].”
BackgroundInfluentialAl-Ghamdi, S. M. G. (2002) · PubMed · Cited by 13
Duszyńska, W., Taccone, F., Hurkacz, M., Wiela−Hojeńska, A., & Kübler, A. (2016) · PubMed · Cited by 13
Self-citationOda, K., Miyakawa, T., Katanoda, T., Hashiguchi, Y., Iwamura, K., Nosaka, K., Yamaguchi, A., Jono, H., & Saito, H. (2020) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2019.10.006 · Cited by 13
Camargo, C., Narula, T., Jackson, D. A., Padro, T., & Freeman, W. D. (2021) · Oxford Medical Case Reports · doi:10.1093/omcr/omab080 · Cited by 12
Gatti, M., Cojutti, P. G., Campoli, C., Caramelli, F., Corvaglia, L., Lanari, M., Pession, A., Ramirez, S., Viale, P., & Pea, F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.755075 · Cited by 12
Puri, V. (2011) · Neurology India · doi:10.4103/0028-3886.76848 · Cited by 12 · cited 6×
“the induction of cerebellar and vestibular system damage with subsequent ataxia after metronidazole, often demonstrated in experimental studies, remains unclear [52].”
BackgroundInfluentialMetronidazole Neurotoxicity: Suspicions Confirmed
Guglielmo, B. J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa400 · Cited by 11 · cited 3×
“Metronidazole has been used for decades as a broad-spectrum antimicrobial agent effective in the treatment of anaerobic bacterial and protozoal infections and in Helicobacter pylori eradication [48].”
BackgroundA Strategy for Hospital Pharmacists to Control Antimicrobial Resistance (AMR) in Japan
Hamada, Y., Ebihara, F., & Kikuchi, K. (2021) · Antibiotics · doi:10.3390/antibiotics10111284 · Cited by 11
Unusual effects of common antibiotics
Ruiz, M. E., & Wortmann, G. W. (2019) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.86a.17050 · Cited by 10 · cited 1×
“The other, unusual effects observed in patients treated with fluoroquinolones (ofloxacin, sparfloxacin) included orofacial dyskinesia and a Tourette-like syndrome [18].”
BackgroundEthambutol optic neuropathy associated with enhancement at the optic chiasm
Lu, P. G., Kung, N. H., & Stavern, G. P. V. (2017) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2017.03.001 · Cited by 9
Matusik, É., Lambiotte, F., Toné, A., & Lemtir, J. (2020) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2020.11.011 · Cited by 5
Nowe strategie terapeutyczne choroby Alzheimera
Nowak, D., Słupski, W., & Rutkowska, M. (2021) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0014.9532 · Cited by 5
Ye, Q., Wang, G., Wang, Y.-X., Lü, G., & Li, Z. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i13.3070 · Cited by 4 · cited 1×
“Encephalopathy and mononeuritis multiplex are rarely observed during the use of this drug [93].”
BackgroundNON-ANTIBIOTIC USE OF ANTIBIOTICS
Danielewski, M., Ksiądzyna, D., & Szeląg, A. (2018) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.21307/pm-2018.57.4.301 · Cited by 3
Emerging Treatment Options for Complicated Skin and Skin Structure Infections: Oritavancin
Townsend, M. L., Wilson, D. T., Pound, M. W., & Drew, R. H. (2010) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s2228 · Cited by 2 · cited 1×
“Currently available data suggests that the second generation lipoglycopeptides, dalbavancin and oritavancin, have no effect on hearing loss or dysfunction [95,96].”
Background[New therapeutic strategies in Alzheimer's disease].
Salamaca-Gómez, F. (2002) · PubMed · Cited by 1
Research works printed but not linked: 7
- Zagaria M.A.E. Antibiotic therapy: Adverse effects and dosing considerations US Pharm 2013 38 18 20
- Demler T.L. Drug-induced neurologic conditions US Pharm 2014 39 47 51
- Jain K.K. Chapter 1: Epidemiology and Clinical Significance Drug-Induced Neurological Disorders 3rd revised and expanded ed. Hogrefe Publishing Gottingen, Germany 2012 1 5
- Jain K.K. Chapter 2: Pathomechanisms of Drug-Induced Neurological Disorders Drug-Induced Neurological Disorders 3rd revised and expanded ed. Hogrefe Publishing Gottingen, Germany 2012 7 12
- File T.M. Tan J.S. Recommendations for using imipenem-cilastatindthe most broad spectrum antibiotic Hosp. Formul. 1987 22 534 542
- Liu X. Microbiome Yale J. Biol. Med. 2016 89 275 276
- Kathait J. Rawat A.S. Beta-lactam antibiotics induced neurotoxicity IOSR J. Pharm. 2020 10 1 7
Cited by
Haddad, N., Carr, M., Balian, S., Lannin, J., Kim, Y., Toth, C., & Jarvis, J. (2022) · Antibiotics · doi:10.3390/antibiotics11121843 · Cited by 96
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Hemdan, M., Abuelhaded, K., Shaker, A. A. S., Ashour, M. M., Abdelaziz, M. M., Dahab, M. I., Nassar, Y. A., Sarguos, A. M. M., Zakaria, P. S., Fahmy, H. A., et al. (2025) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2025.100783 · Cited by 56
An overview of ATP synthase, inhibitors, and their toxicity
Althaher, A. R., & Alwahsh, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22459 · Cited by 45
The Crosstalk between Microbiome and Mitochondrial Homeostasis in Neurodegeneration
Borbolis, F., Mytilinaiou, E., & Palikaras, K. (2023) · Cells · doi:10.3390/cells12030429 · Cited by 46
Metadata
- Authors
- Hurkacz, M., Dobrek, L., & Wiela-Hojeńska, A.
- Affiliations
- Wroclaw Medical University (PL)
- Department of Clinical Pharmacology, Wroclaw Medical University, 50-556 Wroclaw, Poland
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2021-12-09
- Volume
- 26
- Issue
- 24
- Pages
- 7456
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC8708917
- OpenAlex
- W4200466444
- Cited by
- 60
- References
- 135
- Citations by year
- 2026: 13 · 2025: 9 · 2024: 13 · 2023: 18 · 2022: 7
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- antibiotics, drug-induced neurotoxicity, neuroprotection, beta-lactam antibiotics, quinolones, GABA transmission, benzodiazepine receptor, antibiotic resistance, gut dysbiosis, rifaximin, Alzheimer's disease, Parkinson's disease, neuroinflammation, adverse drug reactions
- MeSH terms
- Neuroprotection, Animals, Anti-Bacterial Agents, Humans, Nervous System, Neuroprotective Agents, Neurotoxicity Syndromes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.